# Tuge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tuge

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.tugemedical.com
- Total disclosed funding: $35M
- Latest round: Series B (Apr 10, 2024)
- Investors on record: 8

## About

Based in Nanjing, China and established in 2018, Tuge operates as a medical device provider which specializes in medical endoscope and surgical equipment. The company has a R&D center in Nanjing. As of 2024, the company has more than 100 employees. In 2020, it acquired ISO13485, ISO9001, and ISO14001 system certifications. In April 2024, the firm raised a series B funding for CNY 200 million.

The company’s main business is the research, development, and commercialization of advanced medical imaging devices for minimally invasive surgeries. The company’s self-developed products include endoscopic camera systems and integrated digital operating room solutions. Its products are used in the field of healthcare, specifically in hospitals and surgical centers, to enhance surgical outcomes through high-definition imaging and streamlined operating room management.

The company’s revenue is generated by providing medical electronic endoscopes and digital integrated operating room solutions.

The company will use the series B funding for continued investment in the commercial promotion of minimally invasive surgical imaging equipment and the research and development of new products.

## Funding rounds

- Series B, Apr 10, 2024, $28M — Shanghai Orient Securities Innovation Investment, LongRiver Investments
- Series A, Jul 31, 2020, $7.2M — Zijin Venture Capital, Nanjing Qilin Entrepreneurship Investment, Shanghai Lianhe Investment, Xinliuyu Investment Management
- Angel, Oct 29, 2018 — Casstar Capital, CAS Venture Capital, Xinliuyu Investment Management

## Investors

- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Angel
- CAS Venture Capital (https://capitalatlas.ai/funds/cas-venture-capital) — Angel
- Xinliuyu Investment Management — Angel, Series A
- Zijin Venture Capital (https://capitalatlas.ai/funds/zijin-venture-capital) — Series A
- Nanjing Qilin Entrepreneurship Investment — Series A
- Shanghai Lianhe Investment — Series A
- Shanghai Orient Securities Innovation Investment — Series B
- LongRiver Investments (https://capitalatlas.ai/funds/longriver-investments) — Series B